Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity

A diverse portfolio of SARS-CoV-2 vaccine candidates is needed to combat the evolving COVID-19 pandemic. Here, we developed a subunit nanovaccine by conjugating SARS-CoV-2 Spike protein receptor binding domain (RBD) to the surface of oxidation-sensitive polymersomes. We evaluated the humoral and cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Volpatti, Lisa R., Wallace, Rachel P., Cao, Shijie, Raczy, Michal M., Wang, Ruyi, Gray, Laura T., Alpar, Aaron T., Briquez, Priscilla S., Mitrousis, Nikolaos, Marchell, Tiffany M., Sasso, Maria Stella, Nguyen, Mindy, Mansurov, Aslan, Budina, Erica, Solanki, Ani, Watkins, Elyse A., Schnorenberg, Mathew R., Tremain, Andrew C., Reda, Joseph W., Nicolaescu, Vlad, Furlong, Kevin, Dvorkin, Steve, Yu, Shann S., Manicassamy, Balaji, LaBelle, James L., Tirrell, Matthew V., Randall, Glenn, Kwissa, Marcin, Swartz, Melody A., Hubbell, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043456/
https://www.ncbi.nlm.nih.gov/pubmed/33851166
http://dx.doi.org/10.1101/2021.04.08.438884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043456/
https://www.ncbi.nlm.nih.gov/pubmed/33851166
http://dx.doi.org/10.1101/2021.04.08.438884

Ejemplares similares